EBS Financial Facts
Weighted-average number of shares - basic: 35.97MCost of product sales: 5.7M
See Full Income Statement
Accrued expenses and other current liabilities: 1.52M
Inventories: 22.15M
See Full Balance Sheet
Earnings History for Emergent BioSolutions, Inc. (EBS)
|
Expand Research on EBS
| Next EPS Date | 8/1/13 *Est. | EPS Growth Rate | -900.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -18.0% | Revenue Growth Rate | -14.3% *Last Qtr. |
| Average % Move 1-Wk after EPS | +0.5% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/8/12  |
 |
Q411 | $0.78 | $0.72 | +$0.06 | $107.95M | $109.32M | N/A / N/A | = | -2.7% | Details |
| 3/10/11 |
|
Q410 | $0.78 | $0.67 | +$0.11 | $103.2M | $102.03M | N/A / N/A | = | -36.6% | Details |
| 3/7/13 |
|
Q412 | $0.44 | $0.45 | -$0.01 | $94.6M | $95.09M | N/A / N/A | = | -6.3% | Details |
| 8/4/11 |
|
Q211 | $0.40 | $0.34 | +$0.06 | $88.1M | $84.2M | N/A / N/A | = | -21.7% | Details |
| 8/2/12 |
|
Q212 | $0.21 | $0.23 | -$0.02 | $70.4M | $76.2M | N/A / N/A | = | -0.7% | Details |
| 11/1/12 |
|
Q312 | $0.18 | $0.22 | -$0.04 | $66.6M | $73.53M | N/A / N/A | = | +7.2% | Details |
| 11/3/11 |
|
Q311 | $0.04 | $0.10 | -$0.06 | $58.8M | $63.59M | N/A / N/A | = | -23.3% | Details |
| 5/3/12 |
|
Q112 | -$0.02 | -$0.15 | +$0.13 | $50.3M | $47.32M | N/A / N/A | = | +3% | Details |
